Results 161 to 170 of about 23,326 (221)

Expanding treatment options in chronic spontaneous urticaria: the emerging role of dupilumab. [PDF]

Ann Med Surg (Lond)
Fathima Haseena H, Kumari S, Jaber Amin MH.   +2 more
europepmc   +1 more source

Pemphigoid Gestationis Refractive to Dual Systemic Therapy Treated With Dupilumab [PDF]

Ahmed Abid, Ahmed Abid, Ali Abid, Ali Abid, Kelvin Truong, Jing Jing Li, Paul Weller   +6 more
openalex   +1 more source

Head and Neck Dermatitis in Atopic Dermatitis: A Narrative Review of Pathogenesis, Clinical Challenges, and Therapeutic Strategies. [PDF]

Antibodies (Basel)
Lauletta G, Patruno C, Brescia C, Cosenza A, D'Elia C, Ventura V, Martina E, Napolitano M.   +7 more
europepmc   +1 more source

Molecular characterization of atopic dermatitis:a meta-analysis [PDF]

, 2016
Ewald, David Adrian
core  

Efficacy and Safety of Dupilumab in Children With Moderate-to-Severe Asthma: A Systematic Review of Emerging Phase 3 Evidence. [PDF]

Pediatr Pulmonol
Ghadah A, Aryam A, Shahad A, Hatun A, Amani A, Zinab B, Anoud A, Abdulmajeed A, Tamer A.   +8 more
europepmc   +1 more source

Retrospective Study of Severe Atopic Disease in Young Children (0-5 Years) Managed with Dupilumab Highlights Significant Comorbidities. [PDF]

Children (Basel)
Fagan EF, Hawryluk EB, Jackson-Cowan L.
europepmc   +1 more source

Evolving trends in dupilumab use for chronic rhinosinusitis with nasal polyps (CRSwNP): a 4-year cohort analysis. [PDF]

Sci Rep
Huber P, Gröger M, Stihl C, Frankenberger H, Gellrich D.   +4 more
europepmc   +1 more source

Efficacy and safety of dupilumab in pediatric patients aged 6 months to 11 years with erythrodermic atopic dermatitis: A post-hoc analysis of 3 clinical trials

Amy S. Paller, Elaine C. Siegfried, Michael J. Cork, Kenji Kabashima, Peter D. Arkwright, Edyta Gębska, Zhen Chen, Joseph Zahn, Ana B. Rossi   +8 more
openalex   +2 more sources

Dupilumab-Induced Myalgia and Enthesitis in a Pediatric Patient Treated for Severe Atopic Dermatitis. [PDF]

Cureus
Sabsabee M, Salman A, Alketbi S, Al Hamdani M, Nasreldien A.   +4 more
europepmc   +1 more source

Improvement of Low-Dose Abrocitinib-Resistant Lichen Amyloidosis with Dupilumab: Two Case Reports. [PDF]

Clin Cosmet Investig Dermatol
Zhang W, Mao D, Zhou C, Wen G.
europepmc   +1 more source